(Q38461260)

English

Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics

scientific article published on June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Miller MC

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

O'Dowd GJ

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Partin AW

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Veltri RW

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1105-1111

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of complexed PSA improves specificity for early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter comparison of the diagnostic performance of free prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of complexed PSA in the differential diagnosis between prostate cancer and benign prostate hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900953-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(01)00953-0

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38461260&oldid=1760882517"